Cargando…
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution
Niclosamide is an FDA-approved anthelmintic that is being studied in clinical trials as a chemotherapeutic and broad-spectrum antiviral. Additionally, several other applications are currently in the preclinical stage. Unfortunately, niclosamide is a poorly water soluble molecule, with reduced oral b...
Autores principales: | Jara, Miguel O., Warnken, Zachary N., Sahakijpijarn, Sawittree, Thakkar, Rishi, Kulkarni, Vineet R., Christensen, Dale J., Koleng, John J., Williams, Robert O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785291/ https://www.ncbi.nlm.nih.gov/pubmed/36559062 http://dx.doi.org/10.3390/pharmaceutics14122568 |
Ejemplares similares
-
Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study
por: Jara, Miguel O., et al.
Publicado: (2021) -
Niclosamide inhalation powder made by thin-film freezing: Multi-dose tolerability and exposure in rats and pharmacokinetics in hamsters
por: Jara, Miguel O., et al.
Publicado: (2021) -
In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters
por: Sahakijpijarn, Sawittree, et al.
Publicado: (2021) -
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
por: Sahakijpijarn, Sawittree, et al.
Publicado: (2020) -
Impact of Laser Speed and Drug Particle Size on Selective Laser Sintering 3D Printing of Amorphous Solid Dispersions
por: Thakkar, Rishi, et al.
Publicado: (2021)